Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.eikolifesciences.com | |
Market Cap | 62.21 Cr. | |
Enterprise Value(EV) | 58.59 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.77 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | 97.65 | Trailing Twelve Months Ending 2022-12 |
Industry PE | 26.51 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 35.04 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.13 | Calculated using Price: 74.80 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.83 Cr. | 8,316,267 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is carrying the business of an investment company and for that purpose to invest in, acquire, sell, transfer, subscribe for, hold and otherwise deal in and invest in any shares, bonds, stocks, obligations issued or guaranteed by any company constituted and carrying on business in India or elsewhere and debentures, debenture-stocks, bonds, obligations and securities issued or guaranteed by any Government, State, Sovereign, Commissioners Central or Provincial, public body or authority supreme, municipal, local or otherwise in India or elsewhere either out of its own funds or out of funds that it might borrow. |
1 Day |
|
+3.69% |
1 Week |
|
-7.19% |
1 Month |
|
+1.44% |
3 Month |
|
+46.00% |
6 Month |
|
+17.29% |
1 Year |
|
+55.85% |
2 Year |
|
+14.12% |
5 Year |
|
+54.06% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 4.21 | 1.06 | 2.60 | 5.35 | 4.16 | 1.32 | 2.34 | 10.53 | 4.05 | |
Return on Capital Employed (%) | 5.66 | 1.60 | 3.53 | 6.83 | 5.60 | 2.25 | 3.46 | 9.18 | 5.96 | |
Return on Assets (%) | 3.83 | 1.06 | 2.48 | 4.75 | 3.75 | 1.23 | 2.23 | 5.51 | 2.74 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 0 | 3 | 3 | 3 | 6 | 5 | 5 | 13 | 29 | 29 | |
Non Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Curr. Liab. | 0 | 0 | 0 | 0 | 0 | 0 | 4 | 6 | 1 | ||
Minority Int. | |||||||||||
Equity & Liab. | 0 | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 30 | |
Non Curr. Assets | 0 | 3 | 3 | 3 | 5 | 5 | 6 | 6 | 22 | 21 | |
Curr. Assets | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 11 | 12 | 9 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 0 | 3 | 3 | 4 | 6 | 6 | 6 | 17 | 35 | 30 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 0 | 0 | 1 | 0 | 0 | 0 | 12 | 25 | 17 | ||
Other Income | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||
Total Income | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 12 | 26 | 18 | |
Total Expenditure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -11 | -24 | -16 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
Depreciation | 0 | 0 | 0 | 0 | 0 | -1 | -1 | ||||
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | |
Adjusted EPS | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 2 | 1 | 1 |
Particulars | 9 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | 0 | 0 | 0 | 1 | -1 | -8 | |
Cash Fr. Inv. | -3 | 0 | 0 | -1 | 0 | -1 | -3 | 1 | ||
Cash Fr. Finan. | 0 | 3 | 0 | 0 | 2 | 0 | 0 | 8 | 3 | |
Net Change | 0 | 0 | 0 | 1 | -1 | 0 | 4 | -4 | ||
Cash & Cash Eqvt | 0 | 0 | 1 | 0 | 1 | 0 | 0 | 4 | 0 |
Fri, 17 Mar 2023
Announcement under Regulation 30 (LODR)-Acquisition The Meeting of the Board of Directors of the Company held today i.e. on Friday 17th March 2023 at 2:00 P.M. the Board inter-alia considered and approved the following.1. Considered approved and signed the Memorandum of Understanding (MOU) cum Share Purchase Agreement dated 17th March 2023 with Vivacious Pharmatex Private Limited (VPPL)2. Acquisition of 5% stake of Vivacious Pharmatex Private Limited (VPPL) by way of transfer of shares from the existing shareholders cum Directors of the VPPL at a total consideration not exceeding Rs. 5.10 Lacs. Ref. Annexure A & B for details. |
Fri, 17 Mar 2023
Business Update Business Update |
Mon, 06 Mar 2023
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Laxmikant Kabra HUF |
Tue, 21 Mar 2023 |
|
|
|
|
|